Skip to main content
Erschienen in: Journal of Clinical Immunology 4/2017

09.05.2017 | Original Article

Anti-Pneumococcal Vaccine-Induced Cellular Immune Responses in Post-Traumatic Splenectomized Individuals

verfasst von: Djursun Karasartova, Umut Gazi, Ozgur Tosun, Ayse S. Gureser, Ibrahim T. Sahiner, Mete Dolapci, Aysegul T. Ozkan

Erschienen in: Journal of Clinical Immunology | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Splenectomy is associated with increased risk of overwhelming post-splenectomy infections despite proper anti-pneumococcal vaccination. As most studies concentrated on vaccination-induced humoral immunity, the cellular immune responses triggered in splenectomized patients are not yet well studied. The present study aims to investigate this area as it can contribute to the development of more effective vaccination strategies.

Methods

Five healthy and 14 splenectomized patients were vaccinated with pneumococcal conjugate polysaccharide vaccine (PCV) followed by pneumococcal polysaccharide vaccine according to the guidelines established by Advisory Committee on Immunization Practices. PBMC samples collected 0, 8, and 12 weeks after PCV immunization were in vitro stimulated with PCV. Levels of lymphoproliferation, TH cell differentiation, and cytokine release were assessed by carboxyfluorescein succinimidyl ester labeling, intracellular cytokine staining, and ELISA, respectively.

Results

While TH1-dominated immune response was detected in both groups, asplenic individuals generated significantly lower levels of TH1 cells following in vitro stimulation. Similarly, levels of IFN-γ, IL-4, and IL-17 release and lymphoproliferation were significantly lower in asplenic patients.

Conclusions

According to our data, splenectomy negatively influences the levels of PCV-induced lymphoproliferation, TH1 differentiation, and cytokine release. Besides, PCV failed to induce TH17-dominant immune response which is crucial for protection against extracellular pathogens.
Literatur
2.
Zurück zum Zitat Di Sabatino A, Carsetti R, Corazza GR. Post-splenectomy and hyposplenic states. Lancet. 2011:86–97. Di Sabatino A, Carsetti R, Corazza GR. Post-splenectomy and hyposplenic states. Lancet. 2011:86–97.
3.
Zurück zum Zitat Mawas F, Feavers IM, Corbel MJ. Serotype of Streptococcus pneumoniae capsular polysaccharide can modify the Th1/Th2 cytokine profile and IgG subclass response to pneumococal-CRM197 conjugate vaccines in a murine model. Vaccine. 2000;19:1159–66. CrossRefPubMed Mawas F, Feavers IM, Corbel MJ. Serotype of Streptococcus pneumoniae capsular polysaccharide can modify the Th1/Th2 cytokine profile and IgG subclass response to pneumococal-CRM197 conjugate vaccines in a murine model. Vaccine. 2000;19:1159–66. CrossRefPubMed
4.
Zurück zum Zitat Center for Disease Control and Prevention. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb Mortal Wkly Rep. 2010;59:1102–6. Center for Disease Control and Prevention. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb Mortal Wkly Rep. 2010;59:1102–6.
5.
6.
Zurück zum Zitat Poolman J, Borrow R. Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines. Expert Rev Vaccines. 2011;10:307–22. CrossRefPubMed Poolman J, Borrow R. Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines. Expert Rev Vaccines. 2011;10:307–22. CrossRefPubMed
7.
Zurück zum Zitat Report MW. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the advisory committee on immunization practices (ACIP). Am J Transplant. 2013;13:232–5. CrossRef Report MW. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the advisory committee on immunization practices (ACIP). Am J Transplant. 2013;13:232–5. CrossRef
8.
Zurück zum Zitat Meerveld-Eggink A, de Weerdt O, van Velzen-Blad H, Biesma DH, Rijkers GT. Response to conjugate pneumococcal and Haemophilus influenzae type b vaccines in asplenic patients. Vaccine. 2011;29:675–80. CrossRefPubMed Meerveld-Eggink A, de Weerdt O, van Velzen-Blad H, Biesma DH, Rijkers GT. Response to conjugate pneumococcal and Haemophilus influenzae type b vaccines in asplenic patients. Vaccine. 2011;29:675–80. CrossRefPubMed
10.
Zurück zum Zitat Uslu A, Yetis H, Aykas A, Karagoz A, Dogan M, Simsek C, et al. The efficacy and immunogenecity of Pneumo-23 and ACT-HIB in patients undergoing splenectomy. Turkish J Trauma Emerg Surg. 2006;12:277–81. Uslu A, Yetis H, Aykas A, Karagoz A, Dogan M, Simsek C, et al. The efficacy and immunogenecity of Pneumo-23 and ACT-HIB in patients undergoing splenectomy. Turkish J Trauma Emerg Surg. 2006;12:277–81.
12.
Zurück zum Zitat Hansen K, Singer DB. Asplenic-hyposplenic overwhelming sepsis: postsplenectomy sepsis revisited. Pediatr Dev Pathol. 2001:105–21. Hansen K, Singer DB. Asplenic-hyposplenic overwhelming sepsis: postsplenectomy sepsis revisited. Pediatr Dev Pathol. 2001:105–21.
13.
Zurück zum Zitat Nived P, Jørgensen CS, Settergren B. Vaccination status and immune response to 13-valent pneumococcal conjugate vaccine in asplenic individuals. Vaccine. 2015;33:1688–94. CrossRefPubMed Nived P, Jørgensen CS, Settergren B. Vaccination status and immune response to 13-valent pneumococcal conjugate vaccine in asplenic individuals. Vaccine. 2015;33:1688–94. CrossRefPubMed
15.
Zurück zum Zitat Schutz K, Hughes RG, Parker A, Quinti I, Thon V, Cavaliere M, et al. Kinetics of IgM and IgA antibody response to 23-valent pneumococcal polysaccharide vaccination in healthy subjects. J Clin Immunol. 2013;33:288–96. CrossRefPubMed Schutz K, Hughes RG, Parker A, Quinti I, Thon V, Cavaliere M, et al. Kinetics of IgM and IgA antibody response to 23-valent pneumococcal polysaccharide vaccination in healthy subjects. J Clin Immunol. 2013;33:288–96. CrossRefPubMed
16.
Zurück zum Zitat Karakantza M, Theodorou GL, Mouzaki A, Theodori E, Vagianos C, Maniatis A. In vitro study of the long-term effects of post-traumatic splenectomy on cellular immunity. Scand J Immunol. 2004;59:209–19. CrossRefPubMed Karakantza M, Theodorou GL, Mouzaki A, Theodori E, Vagianos C, Maniatis A. In vitro study of the long-term effects of post-traumatic splenectomy on cellular immunity. Scand J Immunol. 2004;59:209–19. CrossRefPubMed
17.
Zurück zum Zitat Wolf HM, Eibl MM, Georgi E, Samstag A, Spatz M, Uranüs S, et al. Long-term decrease of CD4+CD45RA+ T cells and impaired primary immune response after post-traumatic splenectomy. Br J Haematol. 1999;107:55–68. CrossRefPubMed Wolf HM, Eibl MM, Georgi E, Samstag A, Spatz M, Uranüs S, et al. Long-term decrease of CD4+CD45RA+ T cells and impaired primary immune response after post-traumatic splenectomy. Br J Haematol. 1999;107:55–68. CrossRefPubMed
18.
Zurück zum Zitat Cullingford GL, Watkins DN, Watts ADJ, Mallon DF. Severe late postsplenectomy infection. Br J Surg. 1991:716–21. Cullingford GL, Watkins DN, Watts ADJ, Mallon DF. Severe late postsplenectomy infection. Br J Surg. 1991:716–21.
19.
Zurück zum Zitat Waghorn DJ, Mayon-White RT. A study of 42 episodes of overwhelming post-splenectomy infection: is current guidance for asplenic individuals being followed? J Inf Secur. 1997;35:289–94. Waghorn DJ, Mayon-White RT. A study of 42 episodes of overwhelming post-splenectomy infection: is current guidance for asplenic individuals being followed? J Inf Secur. 1997;35:289–94.
20.
Zurück zum Zitat Cameron PU, Jones P, Gorniak M, Dunster K, Paul E, Lewin S, et al. Splenectomy associated changes in IgM memory B cells in an adult spleen registry cohort. PLoS One. 2011;6. Cameron PU, Jones P, Gorniak M, Dunster K, Paul E, Lewin S, et al. Splenectomy associated changes in IgM memory B cells in an adult spleen registry cohort. PLoS One. 2011;6.
21.
Zurück zum Zitat Venken K, Thewissen M, Hellings N, Somers V, Hensen K, Rummens J-L, et al. A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of autoantigen specific and polyclonal T cell responses. J Immunol Methods. 2007;322(1–2):1–11. Venken K, Thewissen M, Hellings N, Somers V, Hensen K, Rummens J-L, et al. A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of autoantigen specific and polyclonal T cell responses. J Immunol Methods. 2007;322(1–2):1–11.
24.
Zurück zum Zitat Zhang Y, Bliska JB. YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection. Infect Immun. 2010;78:2329–41. Zhang Y, Bliska JB. YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection. Infect Immun. 2010;78:2329–41.
25.
Zurück zum Zitat Wuorimaa T, Kayhty H, Eskola J, Bloigu A, Leroy O, Surcel HM. Activation of cell-mediated immunity following immunization with pneumococcal conjugate or polysaccharide vaccine. Scand J Immunol. 2001;53:422–8. CrossRefPubMed Wuorimaa T, Kayhty H, Eskola J, Bloigu A, Leroy O, Surcel HM. Activation of cell-mediated immunity following immunization with pneumococcal conjugate or polysaccharide vaccine. Scand J Immunol. 2001;53:422–8. CrossRefPubMed
26.
Zurück zum Zitat Kamboj KK, Kirchner HL, Kimmel R, Greenspan NS, Schreiber JR. Significant variation in serotype-specific immunogenicity of the seven-valent Streptococcus pneumoniae capsular polysaccharide-CRM197 conjugate vaccine occurs despite vigorous T cell help induced by the carrier protein. J Infect Dis. 2003;187:1629–38. CrossRefPubMed Kamboj KK, Kirchner HL, Kimmel R, Greenspan NS, Schreiber JR. Significant variation in serotype-specific immunogenicity of the seven-valent Streptococcus pneumoniae capsular polysaccharide-CRM197 conjugate vaccine occurs despite vigorous T cell help induced by the carrier protein. J Infect Dis. 2003;187:1629–38. CrossRefPubMed
28.
Zurück zum Zitat Müller C, Zielinski CC, Klepetko W, Knoflach P, Wolf HEM. Phenotypic and functional analysis of cellular cytotoxicity after splenectomy. Int Arch Allergy Appl Immunol. 1988;87:76–88. CrossRefPubMed Müller C, Zielinski CC, Klepetko W, Knoflach P, Wolf HEM. Phenotypic and functional analysis of cellular cytotoxicity after splenectomy. Int Arch Allergy Appl Immunol. 1988;87:76–88. CrossRefPubMed
29.
Zurück zum Zitat Balsalobre C-T. Cellular immunity in splenectomized patients. J Investig Allergol Clin Immunol. 1991;1:235–8. PubMed Balsalobre C-T. Cellular immunity in splenectomized patients. J Investig Allergol Clin Immunol. 1991;1:235–8. PubMed
31.
Zurück zum Zitat Kuranaga N, Kinoshita M, Kawabata T, Shinomiya N, Seki S. A defective Th1 response of the spleen in the initial phase may explain why splenectomy helps prevent a Listeria infection. Clin Exp Immunol. 2005;140:11–21. CrossRefPubMedPubMedCentral Kuranaga N, Kinoshita M, Kawabata T, Shinomiya N, Seki S. A defective Th1 response of the spleen in the initial phase may explain why splenectomy helps prevent a Listeria infection. Clin Exp Immunol. 2005;140:11–21. CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology. 2010:311–21. Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology. 2010:311–21.
33.
Zurück zum Zitat Lu YJ, Gross J, Bogaert D, Finn A, Bagrade L, Zhang Q, et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 2008;4. Lu YJ, Gross J, Bogaert D, Finn A, Bagrade L, Zhang Q, et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 2008;4.
34.
Zurück zum Zitat Hoe E, Boelsen LK, Toh ZQ, Sun GW, Koo GC, Balloch A, et al. Reduced IL-17A secretion is associated with high levels of pneumococcal nasopharyngeal carriage in Fijian children. PLoS One. 2015;10 Hoe E, Boelsen LK, Toh ZQ, Sun GW, Koo GC, Balloch A, et al. Reduced IL-17A secretion is associated with high levels of pneumococcal nasopharyngeal carriage in Fijian children. PLoS One. 2015;10
35.
Zurück zum Zitat Malley R, Srivastava A, Lipsitch M, Thompson CM, Watkins C, Tzianabos A, et al. Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect Immun. 2006;74:2187–95. CrossRefPubMedPubMedCentral Malley R, Srivastava A, Lipsitch M, Thompson CM, Watkins C, Tzianabos A, et al. Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect Immun. 2006;74:2187–95. CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Moffitt KL, Gierahn TM, Lu YJ, Gouveia P, Alderson M, Flechtner JB, et al. TH17-based vaccine design for prevention of streptococcus pneumoniae colonization. Cell Host Microbe. 2011;9:158–65. CrossRefPubMedPubMedCentral Moffitt KL, Gierahn TM, Lu YJ, Gouveia P, Alderson M, Flechtner JB, et al. TH17-based vaccine design for prevention of streptococcus pneumoniae colonization. Cell Host Microbe. 2011;9:158–65. CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Musher DM, Groover JE, Reichler MR, Riedo FX, Schwartz B, Watson DA, et al. Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization. Clin Infect Dis. 1997;24:441–6. CrossRefPubMed Musher DM, Groover JE, Reichler MR, Riedo FX, Schwartz B, Watson DA, et al. Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization. Clin Infect Dis. 1997;24:441–6. CrossRefPubMed
39.
Zurück zum Zitat Sanders ME, Makgoba MW, Shaw S. Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol Today. 1988;9:195–9 Sanders ME, Makgoba MW, Shaw S. Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol Today. 1988;9:195–9
40.
Zurück zum Zitat Akbar AN, Salmon M, Janossy G. The synergy between naive and memory T cells during activation. Immunol Today. 1991;12(6):184–8. Akbar AN, Salmon M, Janossy G. The synergy between naive and memory T cells during activation. Immunol Today. 1991;12(6):184–8.
42.
Zurück zum Zitat Duque A, Rakic P. Different effects of BrdU and 3 H-thymidine incorporation into DNA on cell proliferation, position and fate. J Neurosci. 2011;31:997–1003. CrossRef Duque A, Rakic P. Different effects of BrdU and 3 H-thymidine incorporation into DNA on cell proliferation, position and fate. J Neurosci. 2011;31:997–1003. CrossRef
43.
Zurück zum Zitat Rabian C, Tschöpe I, Lesprit P, Katlama C, Molina J-M, Meynard J-L, et al. Cellular CD4 T cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults. Clin Infect Dis. 2010;50:1174–83. Rabian C, Tschöpe I, Lesprit P, Katlama C, Molina J-M, Meynard J-L, et al. Cellular CD4 T cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults. Clin Infect Dis. 2010;50:1174–83.
Metadaten
Titel
Anti-Pneumococcal Vaccine-Induced Cellular Immune Responses in Post-Traumatic Splenectomized Individuals
verfasst von
Djursun Karasartova
Umut Gazi
Ozgur Tosun
Ayse S. Gureser
Ibrahim T. Sahiner
Mete Dolapci
Aysegul T. Ozkan
Publikationsdatum
09.05.2017
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 4/2017
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-017-0397-3

Weitere Artikel der Ausgabe 4/2017

Journal of Clinical Immunology 4/2017 Zur Ausgabe

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.